Mallinckrodt Reaches $1.6 Billion Deal to Settle Opioid Lawsuits
Mallinckrodt Pharmaceuticals, the largest generic opioid manufacturer in the United States, has tentatively agreed to pay $1.6 billion to settle thousands of lawsuits brought by state and local governments over its role in the opioid crisis. The agreement was endorsed by 47 states and U.S. territories along with a committee of lawyers representing thousands of…